MME and Alzheimer disease: Another physiological substrate for IDE is somatostatin, a neuropeptide that declines in aging and AD, which is also able to bind to and enhance IDE activity towards Aβ through an allosteric action (Ciaccio et al., 2009) and to upregulate NEP expression (Saito et al., 2005).